当前位置:首页 - 行情中心 - 我武生物(300357) - 财务分析 - 现金流量表

我武生物

(300357)

  

流通市值:96.69亿  总市值:104.30亿
流通股本:4.85亿   总股本:5.24亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金532,170,795.94228,767,671.71,101,022,588.47850,177,687.74
  收到的税费返还10,221,578.83---
  收到其他与经营活动有关的现金11,469,466.461,640,423.6233,074,833.8620,446,041.74
  经营活动现金流入小计553,861,841.23230,408,095.321,134,097,422.33870,623,729.48
  购买商品、接受劳务支付的现金7,101,745.573,092,636.1828,296,506.9822,371,170.51
  支付给职工以及为职工支付的现金146,981,054.9878,362,454.12293,250,722.49214,559,678.61
  支付的各项税费82,707,917.2530,501,111.67123,177,647.6357,379,994.65
  支付其他与经营活动有关的现金127,563,275.0963,402,753.79266,176,798.62289,421,808.2
  经营活动现金流出小计364,353,992.89175,358,955.76710,901,675.72583,732,651.97
  经营活动产生的现金流量净额189,507,848.3455,049,139.56423,195,746.61286,891,077.51
二、投资活动产生的现金流量:
  收回投资收到的现金631,542,465.38303,197,865.381,101,588,389741,491,647.25
  取得投资收益收到的现金3,087,706.861,291,608.793,496,824.763,205,479.62
  处置固定资产、无形资产和其他长期资产收回的现金净额6,283.71211.71--
  收到的其他与投资活动有关的现金100,000100,000--
  投资活动现金流入小计634,736,455.95304,589,685.881,105,085,213.76744,697,126.87
  购建固定资产、无形资产和其他长期资产支付的现金27,342,279.219,366,907.59119,347,815.69110,988,794.96
  投资支付的现金546,816,821.66238,672,0001,224,670,000752,760,000
  支付其他与投资活动有关的现金2,451,118.252,451,118.2532,946,107.4531,204,529.99
  投资活动现金流出小计576,610,219.11260,490,025.841,376,963,923.14894,953,324.95
  投资活动产生的现金流量净额58,126,236.8444,099,660.04-271,878,709.38-150,256,198.08
三、筹资活动产生的现金流量:
  取得借款收到的现金5,000,0005,000,00020,000,00020,000,000
  筹资活动现金流入小计5,000,0005,000,00020,000,00020,000,000
  偿还债务支付的现金5,000,0005,000,00027,628,987.8527,628,987.85
  分配股利、利润或偿付利息支付的现金52,424,268.0652,393,601.39115,298,368.9115,179,627.16
  支付其他与筹资活动有关的现金2,553,951.181,538,824.076,181,817.095,009,063.52
  筹资活动现金流出小计59,978,219.2458,932,425.46149,109,173.84147,817,678.53
  筹资活动产生的现金流量净额-54,978,219.24-53,932,425.46-129,109,173.84-127,817,678.53
四、汇率变动对现金及现金等价物的影响-11,105.96-6,424.71-7,171.42-4,046.21
五、现金及现金等价物净增加额192,644,759.9845,209,949.4322,200,691.978,813,154.69
  加:期初现金及现金等价物余额120,062,978.78120,062,978.7897,862,286.8197,862,286.81
  期末现金及现金等价物余额312,707,738.76165,272,928.21120,062,978.78106,675,441.5
补充资料:
  净利润208,576,920.39-368,089,245.89-
  资产减值准备3,372,352.37-5,611,447.2-
  固定资产和投资性房地产折旧20,460,224.53-35,408,140.69-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧20,460,224.53-35,408,140.69-
  无形资产摊销7,091,801.96-14,573,789.77-
  长期待摊费用摊销1,429,618.26-1,704,146.99-
  处置固定资产、无形资产和其他长期资产的损失---630,073.33-
  固定资产报废损失93,890.63-344,118.81-
  公允价值变动损失-3,312,651.67--3,425,972.25-
  财务费用406,213.73-793,087.05-
  投资损失-29,032,597.07--2,721,381.62-
  递延所得税-475,793.42--114,111.15-
  其中:递延所得税资产减少-475,862.02-24,690.82-
    递延所得税负债增加68.6--138,801.97-
  存货的减少1,977,053.61-2,975,746.21-
  经营性应收项目的减少-36,781,531.24-9,025,610.68-
  经营性应付项目的增加13,635,903.69--14,206,156.54-
  现金的期末余额312,707,738.76-120,062,978.78-
  减:现金的期初余额120,062,978.78-97,862,286.81-
  现金及现金等价物的净增加额192,644,759.98-22,200,691.97-
公告日期2026-08-282026-04-242026-04-242025-10-24
审计意见(境内)标准无保留意见
TOP↑